RxDoctor Payments Data

Mohammed Salih

Interventional Cardiology · Plano, TXNPI 1255823803

Payments from drug & device makers

$78,147in general payments, 2019–2025

Across 103 payments — averaging $758.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$39K
  • Medtronic$31K
  • Edwards Lifesciences$2K
  • Abiomed$1K
  • Shockwave Medical, Inc$817
  • Philips North America LLC$785
  • plus $3K from 21 others

What the payments were for

  • Grants$65,89284%
  • Travel & lodging$4,8486%
  • Food & beverage$6,9149%
  • Education$4941%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,147 in reported general payments places this provider in the 80th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate129$1,858
Rosuvastatin Calcium17$223
Ranolazine ErRanolazine12$198

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →